Anika Therapeutics, Inc. (ANIK) vs InflaRx N.V. (IFRX)
A side-by-side comparison of Anika Therapeutics, Inc. and InflaRx N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIK
Anika Therapeutics, Inc.
$19.29HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
IFRX
InflaRx N.V.
$1.62HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Total return — ANIK vs IFRX
growth of $100 · dividends reinvested · last 9yANIK -63.1% (-10.5%/yr)IFRX -88.8% (-21.6%/yr)ANIK compounded faster over this window
ANIK IFRX
ANIK vs IFRX: by the numbers
- •ANIK is the larger company ($258M vs $238M market cap).
- •Both run net losses; ANIK's is the smaller (-3.14% vs -155582.08% net margin).
Metrics side by side
Valuation
| Metric | ANIK | IFRX |
|---|---|---|
| Forward P/E | 18.37 | N/A |
| P/S ratio | 2.14 | N/A |
| P/B ratio | 1.88 | 1.43 |
| EV / EBITDA | 477.39 | N/A |
| FCF yield | 0.22% | N/A |
Profitability
| Metric | ANIK | IFRX |
|---|---|---|
| Gross margin | 62.16% | -24677.94% |
| Operating margin | -4.24% | -164525.50% |
| Net margin | -3.14% | -155582.08% |
| ROE | -2.76% | -27.27% |
| ROIC | -3.17% | -25.38% |
Growth (annualized)
| Metric | ANIK | IFRX |
|---|---|---|
| Revenue CAGR (5Y) | -2.48% | N/A |
| FCF CAGR (5Y) | -39.38% | N/A |
| Total return CAGR (5Y) | -13.40% | -7.34% |
Frequently asked
- How have ANIK and IFRX total returns compared?
- Over the past 5 years, ANIK delivered -13.40% and IFRX delivered -7.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.